BIDU-W

9888
70.9005.78% ( -4.350 )
Delay Closed: Nov 17, 16:08:15

Posts

Share your thoughts

What's on your mind?

0 / 2,000
109.5k followers · 4 opinions
▲Bullish75%
25%▼
  • F
    Fattycat
    Pinned

    $BIDU-W(09888.HK)

    🚀 Summary of Baidu Q3 2026 Results: AI Is Truly Powering Its Growth!

    Baidu’s Q3 2026 results are in and they show massive momentum across the company’s full‑stack AI business. Here are the key highlights from the quarter:

    ⚡ Core AI business

    Baidu’s AI‑powered core revenue climbed 37 % year‑on‑year to RMB 13.2 billion, accounting for 53 % of Baidu’s general business revenue.

    ☁️ Booming AI Cloud

    AI Cloud Infrastructure revenue jumped 94 % to RMB 8.2 billion. GPU Cloud revenue grew 191 % and token‑usage revenue on the Qianfan MaaS platform soared an eye‑catching 1,159 % year‑on‑year.

    🚗 Apollo Go self‑driving

    By October 2026, Apollo Go had surpassed 390 million autonomous kilometres across 30 cities, rolling out its driverless services to more markets around the world.

    💻 New AI chip

    The Kunlunxin M100 AI inference chip has been revealed to the public and is on track for mass production by year‑end.

    💰 Strong cash flow

    Baidu’s general business revenue reached RMB 25.0 billion, alongside RMB 2.8 billion in operating cash flow.

    You can view the complete Q3 2026 Financial Performance Infographic below.

    🤔 With AI revenue already making up more than half of Baidu’s core business, do you think the market has fully priced in Baidu’s long‑term AI growth potential?

    ⚠️ Disclaimer: For discussion only, not investment or trading advice. Do your own due diligence.

    Bai du 百度 Baidu Q3 2026 Performance & Management Review EXECUTIVE 66 66 AI-FIRST
  • D
    dingdongbell

    What a discount the AI and Tech market is giving us! However, if you believe AI is going to stop tomorrow, these prices are still expensive. Depends on which side you are on.

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Nvidia Slides 4% Into Wednesday Results

    $NVIDIA(NVDA.US) reports at 5:20am Wednesday after a 4% slide, with its board not weighing a Huang return. Chips sank, $Micron Tech(MU.US) down 8%. At home, the STI is down nearly 1%. Let's dig in 👇💬 ...

  • H
    Heroic Lifesaver

    Tech and AI is priced as if they are going extinct. Contrary to the narratives going around, this is the exact opposite of a bubble! So I am expecting tech and AI to recover strongly very soon.

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Nvidia Slides 4% Into Wednesday Results

    $NVIDIA(NVDA.US) reports at 5:20am Wednesday after a 4% slide, with its board not weighing a Huang return. Chips sank, $Micron Tech(MU.US) down 8%. At home, the STI is down nearly 1%. Let's dig in 👇💬 ...

  • A
    Ally

    If the fed is bringing up the worst case scenario of a AI bubble burst, it seems worrying to investors. I’m staying level headed and continuing to DCA.

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Nvidia Slides 4% Into Wednesday Results

    $NVIDIA(NVDA.US) reports at 5:20am Wednesday after a 4% slide, with its board not weighing a Huang return. Chips sank, $Micron Tech(MU.US) down 8%. At home, the STI is down nearly 1%. Let's dig in 👇💬 ...

  • V
    Vt3

    📌🇺🇸🇸🇬🇨🇳 my advice is the same cash is king and not gung- ho against their governance !! Let see them how they kill each other first!

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Nvidia Slides 4% Into Wednesday Results

    $NVIDIA(NVDA.US) reports at 5:20am Wednesday after a 4% slide, with its board not weighing a Huang return. Chips sank, $Micron Tech(MU.US) down 8%. At home, the STI is down nearly 1%. Let's dig in 👇💬 ...

  • V
    Vt3

    📌🇺🇸⁉️Key Question why the fall? It is still nothing but the governance ? Who is in control of this game now? Do not based on yesterday story is today and onwards that tell the outcome next!!!

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Nvidia Slides 4% Into Wednesday Results

    $NVIDIA(NVDA.US) reports at 5:20am Wednesday after a 4% slide, with its board not weighing a Huang return. Chips sank, $Micron Tech(MU.US) down 8%. At home, the STI is down nearly 1%. Let's dig in 👇💬 ...

  • V
    Vt3

    📌🇺🇸🌎🟥 US stocks plunge $1.4 Trillion as Tech and AI Shares Tumble, as expected not surprise anymore after all things bad had happened right, next is whether we should still buy ANT this week or just wait further? AI bubbles are bursting now…. Or even worst I would expect it without further shock!!

    C
    Captain's Watch
    Featured☕️ [Task Coins Giveaway] Daily Market Talk — Nvidia Slides 4% Into Wednesday Results

    $NVIDIA(NVDA.US) reports at 5:20am Wednesday after a 4% slide, with its board not weighing a Huang return. Chips sank, $Micron Tech(MU.US) down 8%. At home, the STI is down nearly 1%. Let's dig in 👇💬 ...

  • M
    Minerva Capital

    Leadership vacuum meets earnings and a mega-IPO

    Monday opens with a risk-off tilt as the AI complex digests the aftershocks of Jensen Huang’s resignation. Nasdaq 100 futures are down ~0.9–1.5%, S&P 500 futures off ~0.4–0.7%, and Dow futures roughly flat to modestly lower. Tech and semiconductors are the clear drag after last week’s leadership shock at $NVIDIA(NVDA.US) wiped roughly $1.9T in market value from the stock’s October peak.

    $NVIDIA(NVDA.US) and the AI trade

    $NVIDIA(NVDA.US) is down 2–4% in premarket, extending its longest weekly losing streak in years after Huang stepped down effective immediately on November 12 amid reports of extramarital affairs (one involving a woman U.S. authorities suspect of Chinese intelligence ties, and another with a direct-report employee). CFO Colette Kress is interim CEO; the board is searching internal and external candidates. Options imply a roughly ±7% move around tomorrow’s print (after the close). Street expectations sit near $109B revenue and ~90% EPS growth, but the real focus is whether new leadership reaffirms the bullish multi-year outlook or injects caution on supply, China exposure, or customer financing.

    The broader complex is soft: $AMD(AMD.US), $Intel(INTC.US), $Broadcom(AVGO.US), and $Micron Tech(MU.US) are all lower premarket. A Commerce interim rule limiting remote access to advanced AI chips/servers from certain countries (framed as closing a post-scandal loophole) is adding incremental pressure. FinTwit is split—some see a setup for a bounce into the print if numbers hold, others flag that founder-CEO exit plus weak succession planning is a genuine valuation overhang regardless of the quarter.

    Anthropic’s IPO (ticker ANT, pricing Wednesday, trading Thursday) is the other major test. Price range $70–$78 implies up to ~$1.4T fully diluted; the deal is heavily oversubscribed with a large strategic placement ($26B from $Alphabet(GOOGL.US), $NVIDIA(NVDA.US), $AMD(AMD.US) and others) and elevated retail allocation. Strong run-rate revenue (~$81B) is real, but the timing against $NVIDIA(NVDA.US) volatility and higher rates is not ideal. Experts note this is less a pure demand story and more a stress test of whether the AI narrative can absorb governance and financing questions without multiple compression.

    Pre-market movers on volume

    ‣ $Telus(TU.US) (+20%+ range): Telus confirmed an unsolicited, non-binding proposal from Québecor at ~$19.45/share in cash and stock (~60% premium to recent close). Special committee is reviewing; it flags regulatory and execution risks under Canadian telecom rules and is exploring alternatives. Classic M&A gapper, but deal probability is not 100%.

    ‣ $Lexeo Therapeutics(LXEO.US) (+20–25%): Positive interim Phase 1/2 data for LX2020 in PKP2 arrhythmogenic cardiomyopathy—80% mean reduction in NSVT and 44% in PVC burden in high-dose cohorts. FDA open to NSVT as a primary surrogate for a potential accelerated-approval path. Data-driven biotech move with a clearer regulatory signal.

    ‣ $Summit Therapeutics(SMMT.US) (down mid-teens): FDA issued a Complete Response Letter for ivonescimab (HARMONi trial). Strong PFS benefit did not translate to statistically significant overall survival; agency said PFS alone does not support approval. Classic binary biotech outcome—stock had run into the decision.

    ‣ Smaller names: $Greenpower Motor(GP.US), $Akanda(AKAN.US), $Clearone(CLRO.US), $Highway(HIHO.US) seeing large percentage moves (momentum, special dividend, prior fleet-related news). High-beta, low-float dynamics dominate; these rarely hold cleanly into the regular session. Crypto-proxies and inverse semis ($SOXS, etc.) are also active as the AI complex softens.

    Earnings calendar – the week that matters

    Today is lighter: $Baidu(BIDU.US), $XPeng(XPEV.US), $Tyson Foods(TSN.US) before the open. The density hits Tuesday–Thursday:

    ‣ Tuesday: $Home Depot(HD.US) and $Disney(DIS.US) before open; $NVIDIA(NVDA.US) after close.

    ‣ Wednesday: $Target(TGT.US), $Lowes(LOW.US) before open; $Palo Alto Networks(PANW.US) after close.

    ‣ Thursday: $Walmart(WMT.US) before open; $Alibaba(BABA.US) also on the card.

    Retailers will be watched for consumer health amid sticky inflation; $NVIDIA(NVDA.US) remains the clear market-moving print.

    Macro and Fed

    Hot recent inflation prints have shifted the narrative. Markets are pricing a December hike (with some discussion of 50 bp), and officials are leaning hawkish. Kansas City’s Schmid said inflation is “uncomfortably above” target and the Fed “has some work to do.” Jefferson is taking cues primarily from inflation. Today: Barr (AI/financial stability), Williams, and Chair Warsh (opening remarks at the SF Fed productivity/jobs task force conference focused on AI/superintelligence impacts). Yields remain elevated (~5.1%+ on the 10-year). Oil is quieter despite ongoing Strait of Hormuz noise. Trump–Xi (and Putin) meetings later in the week are on the radar for any tech or geopolitical signal.

    Bottom line for swing traders

    The dominant theme is AI narrative stress—leadership uncertainty at the sector’s anchor plus a massive IPO in a higher-rate environment. Catalysts (earnings, IPO, Fed speakers, any further China-related chip rules) can move the complex quickly. Single-stock gaps on real news ($Telus(TU.US), $Lexeo Therapeutics(LXEO.US), $Summit Therapeutics(SMMT.US)) are cleaner setups than pure momentum names. Position sizing matters; implied moves are wide.

    NFA / DYOR. This is not investment advice. Markets move fast and positions can lose money. Do your own research.

  • D
    Dolphin Research

    Baidu (Trans): AI cloud infra +94%, ads still under pressure

    AI cloud infra revenue rose 94% YoY, while GPU cloud was up 191%. This lifted BIDU's core business revenue back to a modest +1% growth.

    Ads remain weighed by macro headwinds, tougher competition, and the ongoing AI search revamp, putting near-term margins under pressure. The company is securing compute demand via long-term contracts with upfront payments and plans to pay its first dividend by year-end.

    11 Bai ldu 百度
    Conference MinutesBaidu